Key takeaways from the 7th TimePie Longevity Forum
Live Forever Club - 09-Nov-2026Shanghai forum showcased the rapidly expanding science and business of extending healthy human life
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Shanghai forum showcased the rapidly expanding science and business of extending healthy human life
Warp Sciences trains its lab robots by filming chemists at work
Aleph Surgical raises $7.5m to develop robots that learn complex surgical skills
Celularity will manufacture MuseCells and related therapies in New Jersey
The technology is experimental but could eventually have wider health uses
Finalists will test therapies designed to preserve muscle, brain and immune health
The aim is to make better choices early, before spending years developing a new medicine
Bill Ackman is backing a major centre for neuroscience and brain health
Technology combines health scans and data to spot potential health risks before symptoms appear
Scientists are testing a longevity gene linked to healthy ageing
United Therapeutics bets $140 million on experimental thymus regeneration
A major new investment will help the anti-ageing biotech test whether old cells can be partly reset to treat age-related illness
AI drug discovery firm Insilico joins Human Longevity spinout HLFM
Pandorum Technologies secures new funding to develop “programmable” treatments that could repair damaged eyes and other organs
Why the organisation is cutting jobs to focus on using artificial intelligence to tackle disease
Merge Labs is developing a non-invasive brain-computer interface
Biobeat secures $50 million to expand its cuffless technology
UK biotech aims to bring eye therapy from the operating theatre to the clinic
New funding gives the regenerative biotech breathing space to prioritise placental cell therapies
New funding backs glycan biomarkers to help doctors track inflammation and biological age
Combining repair therapies in mice could redefine how science tackles aging itself
Fresh funding backs DNA origami nanobots aimed at safer, more precise gene therapies
OpenAI-backed Chai raises $130M to accelerate drug and antibody design with AI
A “lab-in-a-loop” platform could speed longevity drug discovery by learning from every experiment
Subsense advances non-surgical BCI tech with new $10M to speed preclinical research